Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents-Reference-Cited by-同舟云学术

Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents

Published:2018-09 Issue: Volume:157 Page:1017-1030
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Szűcs Zsolt,Kelemen Viktor,Le Thai Son,Csávás Magdolna,Rőth Erzsébet,Batta Gyula,Stevaert Annelies^ORCID,Vanderlinden Evelien,Naesens Lieve,Herczegh Pál,Borbás Anikó^ORCID

Funder

National Research, Development and Innovation Office

European Regional Development Fund

Hungarian Academy of Sciences

Gedeon Richter's Talentum Foundation

European Social Fund

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference35 articles.

1. Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: systematic literature review and meta-analysis;Coleman;Influenza Other Respir. Viruses.,2018

2. Emerging antiviral strategies to interfere with influenza virus entry;Vanderlinden;Med. Res. Rev.,2014

3. Antiviral therapies on the horizon for influenza;Naesens;Curr. Opin. Pharmacol.,2016

4. Adamantane-resistant influenza A viruses in the world (1902-2013): frequency and distribution of M2 gene mutations;Dong;PLoS One,2015

5. Influenza virus resistance to neuraminidase inhibitors;Samson;Antivir. Res.,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amphiphilic Sialic Acid Derivatives as Potential Dual-Specific Inhibitors of Influenza Hemagglutinin and Neuraminidase;International Journal of Molecular Sciences;2023-12-08

2. Computational Chemistry Study of Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates as Therapeutic Drugs;Carotenoids - New Perspectives and Application;2022-10-05

3. Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteria;Scientific Reports;2022-09-26

4. Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014-2022;ACS INFECT DIS;2022

5. Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014–2022;ACS Infectious Diseases;2022-07-27